Critical

Staphylococcal toxic shock syndrome

Toxin-mediated · Dermatology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Toxin-mediated multisystem illness from Staphylococcus aureus (tampons, wounds, packing, skin infection) with fever, diffuse macular erythroderma, hypotension and later desquamation.

Red flags

  • Hypotension/shock
  • Multi-organ dysfunction
  • Rapid progression
  • Diffuse erythroderma with fever

Assessment

Differential diagnosis

  • Streptococcal toxic shock
  • Septic shock
  • Kawasaki disease
  • Drug reaction (DRESS/SJS)
  • Scarlet fever

Investigations

  • FBC, U&E, LFTs, CK, coagulation, lactate
  • Blood cultures and cultures of any focus
  • Remove and culture any foreign material (tampon/packing)
  • CRP and septic screen

Management

  • Resuscitate aggressively for shock (fluids +/- vasopressors)
  • Identify and remove the source (tampon, packing, debride infected wound)
  • Start antibiotics including an antistaphylococcal agent plus a toxin-suppressing agent (clindamycin)
  • Consider IV immunoglobulin in severe/refractory shock
  • Supportive organ care in critical care
  • Monitor for later desquamation and complications

Drugs & doses

Antistaphylococcal antibiotic (e.g. flucloxacillin, or vancomycin if MRSA) plus clindamycin
IV crystalloid resuscitation and vasopressors
IV immunoglobulin for severe cases
Source control (removal/debridement)

Disposition

Admit to ICU/HDU; involve microbiology.

Complications & pitfalls

  • Multi-organ failure
  • Death
  • Desquamation and long-term sequelae

Exam pearls

  • Source control is essential - remove tampons/packing
  • Add clindamycin to suppress toxin production
  • Desquamation of palms/soles occurs during recovery

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.